Carotid artery stenting: rationale, technique, and current concepts

Carotid artery stenosis remains a leading cause of stroke, particularly among aging populations. Non-invasive imaging has increased detection rates of carotid plaque. Symptomatic and asymptomatic stenoses differ in clinical behavior. Two large randomized trials confirmed carotid endarterectomy's value in severe symptomatic cases. But benefits decline with less severe stenosis. Medical treatment has advanced since those trials began. Carotid stenting offers a less invasive alternative. It may avoid surgical risks like cranial nerve damage or heart attack. Yet, evidence remains limited for stenting as a primary treatment. Ongoing trials aim to clarify its role in patient care.

This analysis reviews the rationale and current status of carotid artery stenting. It aims to clarify when stenting might be preferable to surgery. The focus is on high-risk surgical patients who may benefit more from endovascular approaches. The study also examines gaps in evidence from randomized trials. It considers how medical treatment advancements affect surgical outcomes. The goal is to inform clinical decision-making. It addresses the uncertainty around stenting's role in stroke prevention. The review highlights the need for updated trial data.

The study synthesizes findings from two major randomized controlled trials on carotid endarterectomy. It evaluates the effectiveness of medical treatment over time. The authors compare surgical risks with those of endovascular procedures. They assess the role of carotid stenting in high-risk surgical patients. The analysis includes a review of ongoing randomized trials comparing stenting and surgery. It considers anatomical and procedural factors affecting outcomes. The approach emphasizes evidence-based practice guidelines. The review does not include patient-level data but focuses on trial-level findings.

Carotid endarterectomy reduces stroke risk in severe symptomatic stenosis cases. Benefits diminish for moderate stenosis and are harmful for less than 50% blockage. Asymptomatic patients derive limited surgical benefit. Medical treatment has improved since early trials began. Carotid stenting avoids surgical risks like cranial nerve palsy. But trials have not proven stenting as a routine alternative to surgery. Stenting may be suitable for high-risk surgical patients. Ongoing randomized trials will provide clearer evidence soon.

Carotid artery stenting may offer advantages over surgery in high-risk patients. But current evidence does not support it as a routine alternative to endarterectomy. Symptomatic severe stenosis remains best treated surgically. Asymptomatic cases require careful risk-benefit analysis. Medical treatment improvements must be considered when interpreting trial results. Ongoing trials will clarify stenting's role in stroke prevention. Until then, stenting should be reserved for specific patient groups. The authors suggest waiting for trial results before expanding stenting indications.